Cargando…
Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma
Proteasome inhibitors are an important part of our chemotherapeutic armamentarium against multiple myeloma, but the vast majority of patients eventually develop drug-resistant disease through incompletely understood mechanisms. Comparison of gene expression profiles (GEPs) of bortezomib-resistant (B...
Autores principales: | Wang, Hua, Baladandayuthapani, Veerabhadran, Wang, Zhiqiang, Lin, Heather, Berkova, Zuzana, Davis, Richard E., Yang, Lin, Orlowski, Robert Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768369/ https://www.ncbi.nlm.nih.gov/pubmed/29371952 http://dx.doi.org/10.18632/oncotarget.23017 |
Ejemplares similares
-
Protein Targeting Chimeric Molecules Specific for Bromodomain and Extra-terminal Motif Family Proteins are Active Against Pre-Clinical Models of Multiple Myeloma
por: Zhang, Xiaohui, et al.
Publicado: (2018) -
Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma
por: Dai, Qingqing, et al.
Publicado: (2022) -
Bayesian Joint Selection of Genes and Pathways: Applications in Multiple Myeloma Genomics
por: Zhang, Lin, et al.
Publicado: (2014) -
Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma
por: Dai, Qingqing, et al.
Publicado: (2022) -
Watch the GAP: Emerging Roles for IQ Motif-Containing GTPase-Activating Proteins IQGAPs in Hepatocellular Carcinoma
por: Schmidt, Valentina A.
Publicado: (2012)